|
KMID : 1204720170100020119
|
|
International Journal of Stem Cells
2017 Volume.10 No. 2 p.119 ~ p.128
|
|
|
Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
|
|
Daliri Karim
Ljubimov Alexander V.
Hekmatimoghaddam Seyedhossein
|
|
|
Abstract
|
|
|
|
Glaucoma is the second most common cause of blindness, affecting 70~80 million people around the world. The death of retinal ganglion cells (RGCs) is the main cause of blindness related to this disease. Current therapies do not provide enough protection and regeneration of RGCs. A novel opportunity for treatment of glaucoma is application of technologies related to stem cell and gene therapy. In this perspective we will thus focus on emerging approaches to glaucoma treatment including stem cells and gene therapy.
|
|
|
KEYWORD
|
|
|
Ganglion cells, Gene therapy, Glaucoma, Retina, Stem cells
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|